Evidence map›Paper›PMID 40180894›Full record

ArticleNature communications2025

Plasmid-driven strategies for clone success in Escherichia coli.

Sergio Arredondo-Alonso, Anna K Pöntinen, João A Gama, Rebecca A Gladstone, Klaus Harms, Gerry Tonkin-Hill, Harry A Thorpe, Gunnar S Simonsen, Ørjan Samuelsen, Pål J Johnsen and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. TheMicrobial genomics · 2026
    Article
  10. Plasmid-Driven Resistome Diversity in 9700Antibiotics (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Molecular determinants ofFrontiers in cellular and infection microbiology · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sergio Arredondo-Alonso *Department of Biostatistics, University of Oslo, Oslo, Norway.
Anna K Pöntinen *Department of Biostatistics, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-3160-2042
João A Gama *Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0003-0967-6616
Rebecca A Gladstone *Department of Biostatistics, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-7993-3051
Klaus HarmsDepartment of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0003-1454-0692
Gerry Tonkin-HillDepartment of Biostatistics, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0003-4397-2224
Harry A ThorpeDepartment of Biostatistics, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0001-5895-3232
Gunnar S SimonsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0003-0043-7045
Ørjan SamuelsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0002-5525-2614
Pål J JohnsenDepartment of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0002-6455-6433
Jukka CoranderDepartment of Biostatistics, University of Oslo, Oslo, Norway. jukka.corander@medisin.uio.no.ORCID http://orcid.org/0000-0002-7752-1942
Norwegian E. coli BSI Study Group

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 742158European Research Council 742158
6 · The paper itself

Abstract

Escherichia coli is the most widely studied microbe in history, but the population structure and evolutionary trends of its extrachromosomal elements known as plasmids remain poorly delineated. Here we used long-read technology to high-resolution sequence the entire plasmidome and the corresponding host chromosomes from an unbiased longitudinal survey covering two decades and over 2000 E. coli isolates. We find that some plasmids have persisted in lineages even for centuries, demonstrating strong plasmid-lineage associations. Our analysis provides a detailed map of recent vertical and horizontal evolutionary events involving plasmids with key antibiotic resistance, competition and virulence determinants. We present genomic evidence of both chromosomal and plasmid-driven success strategies adopted by distant lineages by independently inheriting the same genomic elements. Further, we use in vitro experiments to verify the importance of key bacteriocin-producing plasmids for clone success. Our study has general implications for understanding plasmid biology and bacterial evolutionary strategies.

Indexed as

Escherichia coliPlasmidsBacteriocinsChromosomes, BacterialEvolution, MolecularGenome, BacterialPhylogenyBacteriocins

Identifiers

PMID40180894
PMCPMC11968864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.